Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Antiviral Activity in Chronic Hepatitis C
NCT02972723Phase 4Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Mar 2011
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liquid metformin (Aspargo Labs) in hepatitis C (HCV), sponsored by Nottingham University Hospitals. Primary endpoint: Drop of viral load by at least 1 log at 14 days. Started Mar 2011; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02972723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972723.